通过互联网提供的基于暴露的认知行为治疗刺激性肠综合征:临床有效性研究
Hugo Wallén1, Brjánn Ljótsson1, Perjohan Lindfors2
1Division of Psychology, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
The American journal of gastroenterology
|August 28, 2024
概括
通过互联网提供的基于暴露的认知行为疗法 (ECBT) 在现实世界中有效地减少了易怒肠综合征 (IBS) 的症状. 治疗 治疗 治疗
科学领域:
- 胃肠病学 胃肠病学
- 精神病学是一个精神病学.
- 数字健康数字健康
背景情况:
- 刺激性肠综合征 (IBS) 是一种普遍且致残的疾病.
- 饮食和药物治疗对IBS并不总是有效的.
- 对IBS进行心理干预的机会有限,需要技术解决方案.
研究的目的:
- 评估IBS在互联网上提供的基于暴露的认知行为疗法 (ECBT) 在现实世界中的有效性.
- 确认IBS治疗中ECBT的作用机制.
主要方法:
- 309名IBS患者接受了12周的ECBT.
- 监测了患者的结果,包括IBS症状,生活质量,回避行为和焦虑.
- 一个双变的交叉滞后面板模型分析了随着时间的推移症状和避免行为的变化.
主要成果:
- 从基线到治疗后6个月,IBS症状显著下降 (P < 0.001).
- 观察到一个很大的效应大小 (科恩的d=1.30).
- 减少回避行为预测了IBS症状的减少,但不是相反,表明行为变化作为调解者.
结论:
- 通过互联网提供的ECBT是IBS在现实环境中的有效治疗方法.
- 减少回避行为是推动治疗成功的关键机制.
- 对于管理IBS症状,ECBT提供了一个可扩展的解决方案.
相关概念视频
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
152
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
152
Drugs for Treatment of Constipation-Predominant IBS
146
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
146
Irritable Bowel Syndrome I: Introduction
263
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
263
Irritable Bowel Syndrome III: Medical and Nursing Management
187
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
187
Drugs for Treatment of Diarrhea-Predominant IBS
153
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
153
Rational Emotive Behavior Therapy
45
Cognitive-behavioral therapies (CBTs) are grounded in the belief that our thoughts profoundly influence our emotions and actions. Advocates of CBT emphasize three core assumptions: first, that cognitions are identifiable and measurable; second, that they are central to psychological functioning; and third, that irrational or maladaptive beliefs can be replaced with rational and adaptive ones. This transformative approach to therapy has paved the way for specific models such as Albert...
45


